Enanta Pharmaceuticals Inc
ENTA
Revenue
15.13M
▼-3.19M▼-17.41%
3 Months ChangeAssets
280.73M
▼-20.30M▼-6.74%
3 Months ChangeLiabilities
216.02M
▼-5.74M▼-2.59%
3 Months ChangeFree Cash Flow
-25.55M
▲229.00k▲0.8885%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-07
Form 10-Q
ID: 0000950170-24-092714
2024-08-05
Form 8-K
ID: 0000950170-24-090722
2024-05-08
Form 10-Q
ID: 0000950170-24-055581
2024-05-06
Form 8-K
ID: 0000950170-24-053532
2024-03-12
Form 8-K
ID: 0000950170-24-029889
2024-02-08
Form 10-Q
ID: 0000950170-24-012796
2024-02-07
Form 8-K
ID: 0000950170-24-012186
2023-12-26
Form 8-K
ID: 0001193125-23-303014
2023-11-20
Form 8-K
ID: 0000950170-23-065087
2023-08-08
Form 10-Q
ID: 0000950170-23-039754